Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Noa Bregman

Showing results (31-40 of 45) with videos related to

Pageof 5
Sort By:
Brain Structure & Function|July 13, 2016
A cognitive fMRI study in non-manifesting LRRK2 and GBA carriersNoa Bregman, Avner Thaler, Anat Mirelman, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|December 25, 2025
Drug DevelopmentNoa Bregman, Talya Nathan, Dror Shir, et al.
JAMA Neurology|October 11, 2016
High Frequency of GBA Gene Mutations in Dementia With Lewy Bodies Among Ashkenazi JewsTamara Shiner, Anat Mirelman, Mali Gana Weisz, et al.
Journal of Alzheimer'S Disease : JAD|March 1, 2021
The Effect of GBA Mutations and APOE Polymorphisms on Dementia with Lewy Bodies in Ashkenazi JewsTamara Shiner, Anat Mirelman, Yevgenia Rosenblum, et al.
Brain Topography|May 31, 2018
Cerebral Imaging Markers of GBA and LRRK2 Related Parkinson's Disease and Their First-Degree Unaffected RelativesAvner Thaler, Efrat Kliper, Inbal Maidan, et al.
Parkinsonism & Related Disorders|May 23, 2018
Parkinson's disease phenotype is influenced by the severity of the mutations in the GBA geneAvner Thaler, Noa Bregman, Tanya Gurevich, et al.
Alzheimer'S Research & Therapy|May 28, 2025
Lecanemab in clinical practice: real-world outcomes in early Alzheimer's diseaseNoa Bregman, Talya Nathan, Dror Shir, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|August 30, 2024
Effect of GBA1 Mutations and APOE Polymorphisms on Survival and Progression Among Ashkenazi Jews with Dementia with Lewy BodiesTamara Shiner, Gitit Kavé, Anat Mirelman, et al.
BMC Neurology|April 18, 2023
The natural history study of preclinical genetic Creutzfeldt-Jakob Disease (CJD): a prospective longitudinal study protocolNoa Bregman, Tamara Shiner, Gitit Kavé, et al.
European Stroke Journal|September 9, 2022
Preventing post-stroke dementia. The MARCH Trial. Protocol and statistical analysis plan of a randomized clinical trial testing the safety and efficacy of Maraviroc in post-stroke cognitive impairmentEinor Ben Assayag, Jeremy Molad, Estelle Seyman, et al.
Pageof 5

Showing results (31-40 of 45) with videos related to

Sort By:
Pageof 5
Brain Structure & Function|July 13, 2016
A cognitive fMRI study in non-manifesting LRRK2 and GBA carriersNoa Bregman, Avner Thaler, Anat Mirelman, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|December 25, 2025
Drug DevelopmentNoa Bregman, Talya Nathan, Dror Shir, et al.
JAMA Neurology|October 11, 2016
High Frequency of GBA Gene Mutations in Dementia With Lewy Bodies Among Ashkenazi JewsTamara Shiner, Anat Mirelman, Mali Gana Weisz, et al.
Journal of Alzheimer'S Disease : JAD|March 1, 2021
The Effect of GBA Mutations and APOE Polymorphisms on Dementia with Lewy Bodies in Ashkenazi JewsTamara Shiner, Anat Mirelman, Yevgenia Rosenblum, et al.
Brain Topography|May 31, 2018
Cerebral Imaging Markers of GBA and LRRK2 Related Parkinson's Disease and Their First-Degree Unaffected RelativesAvner Thaler, Efrat Kliper, Inbal Maidan, et al.
Parkinsonism & Related Disorders|May 23, 2018
Parkinson's disease phenotype is influenced by the severity of the mutations in the GBA geneAvner Thaler, Noa Bregman, Tanya Gurevich, et al.
Alzheimer'S Research & Therapy|May 28, 2025
Lecanemab in clinical practice: real-world outcomes in early Alzheimer's diseaseNoa Bregman, Talya Nathan, Dror Shir, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|August 30, 2024
Effect of GBA1 Mutations and APOE Polymorphisms on Survival and Progression Among Ashkenazi Jews with Dementia with Lewy BodiesTamara Shiner, Gitit Kavé, Anat Mirelman, et al.
BMC Neurology|April 18, 2023
The natural history study of preclinical genetic Creutzfeldt-Jakob Disease (CJD): a prospective longitudinal study protocolNoa Bregman, Tamara Shiner, Gitit Kavé, et al.
European Stroke Journal|September 9, 2022
Preventing post-stroke dementia. The MARCH Trial. Protocol and statistical analysis plan of a randomized clinical trial testing the safety and efficacy of Maraviroc in post-stroke cognitive impairmentEinor Ben Assayag, Jeremy Molad, Estelle Seyman, et al.
Pageof 5